/PRNewswire/ — NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) (“NeuroSense”), a company developing treatments for severe neurodegenerative diseases, today…
NeuroSense Announces Third Quarter 2023 Financial Results and Provides Business Update
By 
Add A Comment